{"count": 58, "results": [{"_id": "36820569", "pmid": 36820569, "pmcid": "PMC9907997", "title": "Effects of amlodipine combined with atorvastatin on Th17/Treg imbalance and vascular microcirculation in hypertensive patients with atherosclerosis: A double-blind, single-center randomized controlled trial", "journal": "Medicine (Baltimore)", "authors": ["Yang G", "Qiu Y"], "date": "2023-02-10T00:00:00Z", "doi": "10.1097/MD.0000000000032384", "meta_date_publication": "2023 Feb 10", "meta_volume": "102", "meta_issue": "6", "meta_pages": "e32384", "score": 50273.406, "text_hl": "Effects of @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@ combined with @CHEMICAL_Atorvastatin @CHEMICAL_MESH:D000069059 @@@atorvastatin@@@ on Th17/Treg imbalance and vascular microcirculation in @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@hypertensive@@@ @SPECIES_9606 @@@patients@@@ with @<m>DISEASE_Atherosclerosis</m> @DISEASE_MESH:D050197 @@@atherosclerosis@@@: A double-blind, single-center randomized controlled trial", "citations": {"NLM": "Yang G, Qiu Y. Effects of amlodipine combined with atorvastatin on Th17/Treg imbalance and vascular microcirculation in hypertensive patients with atherosclerosis: A double-blind, single-center randomized controlled trial Medicine (Baltimore). 2023 Feb 10;102(6):e32384. PMID: 36820569", "BibTeX": "@article{36820569, title={Effects of amlodipine combined with atorvastatin on Th17/Treg imbalance and vascular microcirculation in hypertensive patients with atherosclerosis: A double-blind, single-center randomized controlled trial}, author={Yang G and Qiu Y}, journal={Medicine (Baltimore)}, volume={102}, number={6}, pages={e32384}}"}}, {"_id": "41006534", "pmid": 41006534, "title": "In vitro and in silico studies and a systematic literature review of antiglycation properties of amlodipine.", "journal": "Sci Rep", "authors": ["Dańkowska K", "Nesterowicz M", "Lauko KK", "Trocka D", "Żendzian-Piotrowska M", "Ładny JR", "Zalewska A", "Żebrowska-Gamdzyk M", "Maciejczyk M"], "date": "2025-09-26T00:00:00Z", "doi": "10.1038/s41598-025-18925-8", "meta_date_publication": "2025 Sep 26", "meta_volume": "15", "meta_issue": "1", "meta_pages": "33277", "score": 50256.37, "text_hl": "In vitro and in silico studies and a systematic literature review of antiglycation properties of @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@.", "citations": {"NLM": "Dańkowska K, Nesterowicz M, Lauko KK, Trocka D, Żendzian-Piotrowska M, Ładny JR, Zalewska A, Żebrowska-Gamdzyk M, Maciejczyk M. In vitro and in silico studies and a systematic literature review of antiglycation properties of amlodipine. Sci Rep. 2025 Sep 26;15(1):33277. PMID: 41006534", "BibTeX": "@article{41006534, title={In vitro and in silico studies and a systematic literature review of antiglycation properties of amlodipine.}, author={Dańkowska K and Nesterowicz M and Lauko KK and Trocka D and Żendzian-Piotrowska M and Ładny JR and Zalewska A and Żebrowska-Gamdzyk M and Maciejczyk M}, journal={Sci Rep}, volume={15}, number={1}, pages={33277}}"}}, {"_id": "34075886", "pmid": 34075886, "title": "Combination of atorvastatin or hydrochlorothiazide/amlodipine with Salvia miltiorrhiza (Danshen) and Pueraria lobata (Gegen) for atherosclerosis, hyperlipidaemia, and hypertension: a preclinical in vivo study (abridged secondary publication).", "journal": "Hong Kong Med J", "authors": ["Cheung DWS", "Koon JCM", "Wong PH", "Yau KC", "Wat ECL", "Chan JYW", "Lau VKM", "Ko ECH", "Waye MMY", "Fung KP"], "date": "2021-06-01T00:00:00Z", "meta_date_publication": "2021 Jun", "meta_volume": "27 Suppl 2", "meta_issue": "3", "meta_pages": "18-22", "score": 50246.645, "text_hl": "Combination of @CHEMICAL_Atorvastatin @CHEMICAL_MESH:D000069059 @@@atorvastatin@@@ or @CHEMICAL_Hydrochlorothiazide @CHEMICAL_MESH:D006852 @@@hydrochlorothiazide@@@/@<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@ with Salvia miltiorrhiza (Danshen) and @SPECIES_3893 @@@Pueraria lobata@@@ (Gegen) for @<m>DISEASE_Atherosclerosis</m> @DISEASE_MESH:D050197 @@@atherosclerosis@@@, hyperlipidaemia, and @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@hypertension@@@: a preclinical in vivo study (abridged secondary publication).", "citations": {"NLM": "Cheung DWS, Koon JCM, Wong PH, Yau KC, Wat ECL, Chan JYW, Lau VKM, Ko ECH, Waye MMY, Fung KP. Combination of atorvastatin or hydrochlorothiazide/amlodipine with Salvia miltiorrhiza (Danshen) and Pueraria lobata (Gegen) for atherosclerosis, hyperlipidaemia, and hypertension: a preclinical in vivo study (abridged secondary publication). Hong Kong Med J. 2021 Jun;27 Suppl 2(3):18-22. PMID: 34075886", "BibTeX": "@article{34075886, title={Combination of atorvastatin or hydrochlorothiazide/amlodipine with Salvia miltiorrhiza (Danshen) and Pueraria lobata (Gegen) for atherosclerosis, hyperlipidaemia, and hypertension: a preclinical in vivo study (abridged secondary publication).}, author={Cheung DWS and Koon JCM and Wong PH and Yau KC and Wat ECL and Chan JYW and Lau VKM and Ko ECH and Waye MMY and Fung KP}, journal={Hong Kong Med J}, volume={27 Suppl 2}, number={3}, pages={18-22}}"}}, {"_id": "26251572", "pmid": 26251572, "pmcid": "PMC4524379", "title": "Combined treatment with olmesartan medoxomil and amlodipine besylate attenuates atherosclerotic lesion progression in a model of advanced atherosclerosis", "journal": "Drug Des Devel Ther", "authors": ["Sievers P", "Uhlmann L", "Korkmaz-Icöz S", "Fastner C", "Bea F", "Blessing E", "Katus HA", "Preusch MR"], "date": "2015-07-29T00:00:00Z", "doi": "10.2147/DDDT.S85203", "meta_date_publication": "2015", "meta_volume": "9", "meta_issue": "", "meta_pages": "3935-42", "score": 50092.46, "text_hl": "Combined treatment with @CHEMICAL_Olmesartan_Medoxomil @CHEMICAL_MESH:D000068557 @@@olmesartan medoxomil@@@ and @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine besylate@@@ attenuates @<m>DISEASE_Atherosclerosis</m> @DISEASE_MESH:D050197 @@@atherosclerotic lesion@@@ progression in a model of advanced @<m>DISEASE_Atherosclerosis</m> @DISEASE_MESH:D050197 @@@atherosclerosis@@@", "citations": {"NLM": "Sievers P, Uhlmann L, Korkmaz-Icöz S, Fastner C, Bea F, Blessing E, Katus HA, Preusch MR. Combined treatment with olmesartan medoxomil and amlodipine besylate attenuates atherosclerotic lesion progression in a model of advanced atherosclerosis Drug Des Devel Ther. 2015;9():3935-42. PMID: 26251572", "BibTeX": "@article{26251572, title={Combined treatment with olmesartan medoxomil and amlodipine besylate attenuates atherosclerotic lesion progression in a model of advanced atherosclerosis}, author={Sievers P and Uhlmann L and Korkmaz-Icöz S and Fastner C and Bea F and Blessing E and Katus HA and Preusch MR}, journal={Drug Des Devel Ther}, volume={9}, pages={3935-42}}"}}, {"_id": "11216089", "pmid": 11216089, "title": "[Effect of amlodipine on the progression of atherosclerosis and the occurrence of clinical events].", "journal": "Ital Heart J Suppl", "authors": ["Eleuteri E"], "date": "2001-01-01T00:00:00Z", "meta_date_publication": "2001 Jan", "meta_volume": "2", "meta_issue": "1", "meta_pages": "85-6", "score": 50077.312, "text_hl": "[Effect of @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@ on the progression of @<m>DISEASE_Atherosclerosis</m> @DISEASE_MESH:D050197 @@@atherosclerosis@@@ and the occurrence of clinical events].", "citations": {"NLM": "Eleuteri E. [Effect of amlodipine on the progression of atherosclerosis and the occurrence of clinical events]. Ital Heart J Suppl. 2001 Jan;2(1):85-6. PMID: 11216089", "BibTeX": "@article{11216089, title={[Effect of amlodipine on the progression of atherosclerosis and the occurrence of clinical events].}, author={Eleuteri E}, journal={Ital Heart J Suppl}, volume={2}, number={1}, pages={85-6}}"}}, {"_id": "29848894", "pmid": 29848894, "title": "Targeting Vascular Inflammaging with Amlodipine for Atherosclerosis Prevention.", "journal": "Int Heart J", "authors": ["Harada M", "Ishizuka M", "Murakami H", "Toko H"], "date": "2018-01-01T00:00:00Z", "doi": "10.1536/ihj.18-212", "meta_date_publication": "2018", "meta_volume": "59", "meta_issue": "3", "meta_pages": "465-466", "score": 50074.52, "text_hl": "Targeting @DISEASE_Vascular_System_Injuries @DISEASE_MESH:D057772 @@@Vascular Inflammaging@@@ with @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@Amlodipine@@@ for @<m>DISEASE_Atherosclerosis</m> @DISEASE_MESH:D050197 @@@Atherosclerosis@@@ Prevention.", "citations": {"NLM": "Harada M, Ishizuka M, Murakami H, Toko H. Targeting Vascular Inflammaging with Amlodipine for Atherosclerosis Prevention. Int Heart J. 2018;59(3):465-466. PMID: 29848894", "BibTeX": "@article{29848894, title={Targeting Vascular Inflammaging with Amlodipine for Atherosclerosis Prevention.}, author={Harada M and Ishizuka M and Murakami H and Toko H}, journal={Int Heart J}, volume={59}, number={3}, pages={465-466}}"}}, {"_id": "10071259", "pmid": 10071259, "title": "Atheroprotection with amlodipine: cells to lesions and the PREVENT trial. Prospective Randomized Evaluation of the Vascular Effects of Norvasc Trial.", "journal": "J Cardiovasc Pharmacol", "authors": ["Tulenko TN", "Brown J", "Laury-Kleintop L", "Khan M", "Walter MF", "Mason RP"], "date": "1999-01-01T00:00:00Z", "doi": "10.1097/00005344-199900002-00005", "meta_date_publication": "1999", "meta_volume": "33 Suppl 2", "meta_issue": "", "meta_pages": "S17-22", "score": 50074.1, "text_hl": "These multiple pharmacologic actions may explain the cellular mechanisms of the atheroprotective effects of @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@ in spontaneous @<m>DISEASE_Atherosclerosis</m> @DISEASE_MESH:D050197 @@@atherogenesis@@@ and in accelerated @<m>DISEASE_Atherosclerosis</m> @DISEASE_MESH:D050197 @@@atherosclerotic syndromes@@@. ", "citations": {"NLM": "Tulenko TN, Brown J, Laury-Kleintop L, Khan M, Walter MF, Mason RP. Atheroprotection with amlodipine: cells to lesions and the PREVENT trial. Prospective Randomized Evaluation of the Vascular Effects of Norvasc Trial. J Cardiovasc Pharmacol. 1999;33 Suppl 2():S17-22. PMID: 10071259", "BibTeX": "@article{10071259, title={Atheroprotection with amlodipine: cells to lesions and the PREVENT trial. Prospective Randomized Evaluation of the Vascular Effects of Norvasc Trial.}, author={Tulenko TN and Brown J and Laury-Kleintop L and Khan M and Walter MF and Mason RP}, journal={J Cardiovasc Pharmacol}, volume={33 Suppl 2}, pages={S17-22}}"}}, {"_id": "11004140", "pmid": 11004140, "title": "Effect of amlodipine on the progression of atherosclerosis and the occurrence of clinical events. PREVENT Investigators.", "journal": "Circulation", "authors": ["Pitt B", "Byington RP", "Furberg CD", "Hunninghake DB", "Mancini GB", "Miller ME", "Riley W"], "date": "2000-09-26T00:00:00Z", "doi": "10.1161/01.cir.102.13.1503", "meta_date_publication": "2000 Sep 26", "meta_volume": "102", "meta_issue": "13", "meta_pages": "1503-10", "score": 50072.477, "text_hl": "Effect of @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@ on the progression of @<m>DISEASE_Atherosclerosis</m> @DISEASE_MESH:D050197 @@@atherosclerosis@@@ and the occurrence of clinical events. ", "citations": {"NLM": "Pitt B, Byington RP, Furberg CD, Hunninghake DB, Mancini GB, Miller ME, Riley W. Effect of amlodipine on the progression of atherosclerosis and the occurrence of clinical events. PREVENT Investigators. Circulation. 2000 Sep 26;102(13):1503-10. PMID: 11004140", "BibTeX": "@article{11004140, title={Effect of amlodipine on the progression of atherosclerosis and the occurrence of clinical events. PREVENT Investigators.}, author={Pitt B and Byington RP and Furberg CD and Hunninghake DB and Mancini GB and Miller ME and Riley W}, journal={Circulation}, volume={102}, number={13}, pages={1503-10}}"}}, {"_id": "9488205", "pmid": 9488205, "title": "Pathophysiology of atherogenesis with special focus on the potential therapeutic effects of amlodipine. Summary.", "journal": "Int J Cardiol", "authors": ["Nilsson J"], "date": "1997-12-31T00:00:00Z", "doi": "10.1016/s0167-5273(97)00251-9", "meta_date_publication": "1997 Dec 31", "meta_volume": "62 Suppl 2", "meta_issue": "", "meta_pages": "S135-6", "score": 50072.137, "text_hl": "Pathophysiology of @<m>DISEASE_Atherosclerosis</m> @DISEASE_MESH:D050197 @@@atherogenesis@@@ with special focus on the potential therapeutic effects of @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@. ", "citations": {"NLM": "Nilsson J. Pathophysiology of atherogenesis with special focus on the potential therapeutic effects of amlodipine. Summary. Int J Cardiol. 1997 Dec 31;62 Suppl 2():S135-6. PMID: 9488205", "BibTeX": "@article{9488205, title={Pathophysiology of atherogenesis with special focus on the potential therapeutic effects of amlodipine. Summary.}, author={Nilsson J}, journal={Int J Cardiol}, volume={62 Suppl 2}, pages={S135-6}}"}}, {"_id": "14996641", "pmid": 14996641, "title": "Amlodipine and atorvastatin in atherosclerosis: a review of the potential of combination therapy.", "journal": "Expert Opin Pharmacother", "authors": ["Jukema JW", "van der Hoorn JW"], "date": "2004-02-01T00:00:00Z", "doi": "10.1517/14656566.5.2.459", "meta_date_publication": "2004 Feb", "meta_volume": "5", "meta_issue": "2", "meta_pages": "459-68", "score": 50071.89, "text_hl": "@<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@Amlodipine@@@ and @CHEMICAL_Atorvastatin @CHEMICAL_MESH:D000069059 @@@atorvastatin@@@ in @<m>DISEASE_Atherosclerosis</m> @DISEASE_MESH:D050197 @@@atherosclerosis@@@: a review of the potential of combination therapy.", "citations": {"NLM": "Jukema JW, van der Hoorn JW. Amlodipine and atorvastatin in atherosclerosis: a review of the potential of combination therapy. Expert Opin Pharmacother. 2004 Feb;5(2):459-68. PMID: 14996641", "BibTeX": "@article{14996641, title={Amlodipine and atorvastatin in atherosclerosis: a review of the potential of combination therapy.}, author={Jukema JW and van der Hoorn JW}, journal={Expert Opin Pharmacother}, volume={5}, number={2}, pages={459-68}}"}}]}